Correlation Between Alterola Biotech and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and Bionoid Pharma, you can compare the effects of market volatilities on Alterola Biotech and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Bionoid Pharma.

Diversification Opportunities for Alterola Biotech and Bionoid Pharma

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Alterola and Bionoid is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Alterola Biotech and Bionoid Pharma

Given the investment horizon of 90 days Alterola Biotech is expected to generate 1.5 times less return on investment than Bionoid Pharma. In addition to that, Alterola Biotech is 1.06 times more volatile than Bionoid Pharma. It trades about 0.07 of its total potential returns per unit of risk. Bionoid Pharma is currently generating about 0.11 per unit of volatility. If you would invest  20.00  in Bionoid Pharma on September 14, 2024 and sell it today you would earn a total of  7.00  from holding Bionoid Pharma or generate 35.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Alterola Biotech  vs.  Bionoid Pharma

 Performance 
       Timeline  
Alterola Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Bionoid Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Alterola Biotech and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alterola Biotech and Bionoid Pharma

The main advantage of trading using opposite Alterola Biotech and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Alterola Biotech and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency